Clinical Trial Detail

NCT ID NCT03520959
Title Synovate Study for Synovial Sarcoma, Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Immune Design
Indications

synovial sarcoma

Therapies

CMB305

Age Groups: child senior adult

Additional content available in CKB BOOST